Disease Burden of Total and Early-Onset Colorectal Cancer in China from 1990 to 2019 and Predictions of Cancer Incidence and Mortality

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179–2185. doi:10.1136/gutjnl-2019-319511
   PubMed Web of Science ®Google Scholar
• Wang W, Yin P, Liu YN, et al. Mortality and years of life lost of colorectal cancer in China, 2005–2020: findings from the national mortality surveillance system. Chin Med J. 2021;134(16):1933–1940. doi:10.1097/CM9.0000000000001625
   PubMed Web of Science ®Google Scholar
• Li N, Lu B, Luo CY, et al. Incidence, mortality, survival, risk factor and screening of colorectal cancer: a comparison among China, Europe, and Northern America. Cancer Lett. 2021;522:255–268. doi:10.1016/j.canlet.2021.09.034
   PubMed Web of Science ®Google Scholar
• World Health Organization Noncommunicable diseases. Available from: https://www.who.int/health-topics/noncommunicable-diseases. Accessed September 5, 2022.
   Google Scholar
• Yang GH, Wang Y, Zeng YX, et al. Rapid health transition in China, 1990-2010: findings from the global burden of disease study 2010. Lancet. 2013;381(9882):1987–2015. doi:10.1016/S0140-6736(13)61097-1
   PubMed Web of Science ®Google Scholar
• Arnold M, Sierra MS, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global patterns and trends in colorectal cancer incidence and mortality. Gut. 2017;66(4):683–691. doi:10.1136/gutjnl-2015-310912
   PubMed Web of Science ®Google Scholar
• Omran S, Barakat H, Muliira JK, McMillan S. Dietary and lifestyle risk factors for colorectal cancer in apparently healthy adults in Jordanian Hospitals. J Cancer Educ. 2017;32(3):447–453. doi:10.1007/s13187-015-0970-5
   PubMed Web of Science ®Google Scholar
• Du LB, Li HZ, Wang YQ, et al. Report of colorectal cancer incidence and mortality in China, 2013. Zhonghua Zhong Liu Za Zhi. 2017;39(9):701–706 Chinese . doi:10.3760/cma.j.issn.0253-3766.2017.09.012
   PubMedGoogle Scholar
• Zhang L, Cao F, Zhang GY, et al. Trends in and predictions of colorectal cancer incidence and mortality in China from 1990 to 2025. Front Oncol. 2019;9:9. doi:10.3389/fonc.2019.00009
   PubMed Web of Science ®Google Scholar
• World Health Organization Ageing and health in China . Available from: https://www.who.int/china/health-topics/ageing. Accessed September 5, 2022.
   Google Scholar
• Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1151–1210 doi:10.1016/S0140-6736(17)32152-9.
   PubMed Web of Science ®Google Scholar
• Vos T, Abajobir AA, Abbafati C, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1211–1259 doi:10.1016/S0140-6736(17)32154-2.
   PubMed Web of Science ®Google Scholar
• Hay SI, Abajobir AA, Abate KH, et al. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the global burden of disease study 2016. Lancet. 2017;390(10100):1260–1344 doi:10.1016/S0140-6736(17)32130-X.
   PubMed Web of Science ®Google Scholar
• Diseases GBD, Injuries C. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet. 2020;396(10258):1204–1222 doi:10.1016/S0140-6736(20)30925-9.
   PubMed Web of Science ®Google Scholar
• Murray CJ, Lopez AD. Measuring the global burden of disease. N Engl J Med. 2013;369(5):448–457. doi:10.1056/NEJMra1201534
   PubMed Web of Science ®Google Scholar
• Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) results. Available from: https://vizhub.healthdata.org/gbd-results/. Accessed May 25, 2022.
   Google Scholar
• Sharma R, Abbasi-Kangevari M, Abd-Rabu R. Global, regional, and national burden of colorectal cancer and its risk factors, 1990–2019: a systematic analysis for the global burden of disease study 2019. Lancet Gastroenterol Hepatol. 2022;7(7):627–647. doi:10.1016/S2468-1253(22)00044-9
   PubMed Web of Science ®Google Scholar
• Fay MP, Feuer EJ. Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med. 1997;16(7):791–801 doi:10.1002/(sici)1097-0258(19970415)16:7<791::aid-sim500>3.0.co;2-#.
   PubMed Web of Science ®Google Scholar
• Kim HJ, Fay MP, Feuer EJ, Midthune DN. Permutation tests for joinpoint regression with applications to cancer rates. Stat Med. 2000;19(3):335–351. doi:10.1002/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z
   PubMed Web of Science ®Google Scholar
• Arnold M, Laversanne M, Brown LM, Devesa SS, Bray F. Predicting the future burden of esophageal cancer by histological subtype: international trends in incidence up to 2030. Am J Gastroenterol. 2017;112(8):1247–1255. doi:10.1038/ajg.2017.155
   PubMed Web of Science ®Google Scholar
• Moller B, Fekjaer H, Hakulinen T, et al. Prediction of cancer incidence in the Nordic countries: empirical comparison of different approaches. Stat Med. 2003;22(17):2751–2766. doi:10.1002/sim.1481
   PubMed Web of Science ®Google Scholar
• Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: age-period and age-cohort models. Stat Med. 1987;6(4):449–467. doi:10.1002/sim.4780060405
   PubMed Web of Science ®Google Scholar
• Wickham H. ggplot2: Elegant Graphics for Data Analysis. New York: Springer-Verlag; 2016.
   Google Scholar
• Haupt S, Caramia F, Klein SL, Rubin JB, Haupt Y. Sex disparities matter in cancer development and therapy. Nat Rev Cancer. 2021;21(6):393–407. doi:10.1038/s41568-021-00348-y
   PubMed Web of Science ®Google Scholar
• Xi Y, Xu PF. Global colorectal cancer burden in 2020 and projections to 2040. Transl Oncol. 2021;14(10):7. doi:10.1016/j.tranon.2021.101174
   Web of Science ®Google Scholar
• Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.21338
   PubMed Web of Science ®Google Scholar
• Feng RM, Zong YN, Cao SM, Xu RH. Current cancer situation in China: good or bad news from the 2018 global cancer statistics? Cancer Commun. 2019;39:12. doi:10.1186/s40880-019-0368-6
   Web of Science ®Google Scholar
• Wilson ML, Fleming KA, Kuti MA, Looi LM, Lago N, Ru K. Pathology and laboratory medicine in low-income and middle-income countries 1: access to pathology and laboratory medicine services: a crucial gap. Lancet. 2018;391(10133):1927–1938. doi:10.1016/S0140-6736(18)30458-6
   PubMed Web of Science ®Google Scholar
• Klarich DS, Brasser SM, Hong MY. Moderate alcohol consumption and colorectal cancer risk. Alcoholism. 2015;39(8):1280–1291. doi:10.1111/acer.12778
   Google Scholar
• Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12):713–732. doi:10.1038/s41575-019-0189-8
   PubMed Web of Science ®Google Scholar
• Song M, Chan AT. Environmental factors, gut microbiota, and colorectal cancer prevention. Clin Gastroenterol Hepatol. 2019;17(2):275–289. doi:10.1016/j.cgh.2018.07.012
   PubMed Web of Science ®Google Scholar
• Zhang TC, Chen H, Yin XL, et al. Changing trends of disease burden of gastric cancer in China from 1990 to 2019 and its predictions: findings from global burden of disease study. Chin J Cancer Res. 2021;33(1):11–26. doi:10.21147/j.issn.1000-9604.2021.01.02
   PubMed Web of Science ®Google Scholar
• Siegel RL, Fedewa SA, Anderson WF, et al. Colorectal cancer incidence patterns in the United States, 1974–2013. J Natl Cancer Inst. 2017;109(8):6. doi:10.1093/jnci/djw322
   Google Scholar
• Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012. Eur J Cancer. 2013;49(6):1374–1403. doi:10.1016/j.ejca.2012.12.027
   PubMed Web of Science ®Google Scholar
• Mitsala A, Tsalikidis C, Pitiakoudis M, Simopoulos C, Tsaroucha AK. Artificial intelligence in colorectal cancer screening, diagnosis and treatment. a new era. Curr Oncol. 2021;28(3):1581–1607. doi:10.3390/curroncol28030149
   PubMed Web of Science ®Google Scholar
• Johdi NA, Sukor NF. Colorectal cancer immunotherapy: options and strategies. Front Immunol. 2020;11:18. doi:10.3389/fimmu.2020.01624
   PubMed Web of Science ®Google Scholar
• Katalin L, Orsolya G, Alexandra K, et al. Potential role of estrogens in colorectal tumour development. Orv Hetil. 2020;161(14):532–543. doi:10.1556/650.2020.31674
   PubMed Web of Science ®Google Scholar
• Low EE, Demb J, Liu L, et al. Risk factors for early-onset colorectal cancer. Gastroenterology. 2020;159(2):492–+. doi:10.1053/j.gastro.2020.01.004
   PubMed Web of Science ®Google Scholar
• Brenner H, Hoffmeister M, Arndt V, Haug U. Gender differences in colorectal cancer: implications for age at initiation of screening. Br J Cancer. 2007;96(5):828–831. doi:10.1038/sj.bjc.6603628
   PubMed Web of Science ®Google Scholar
• Akimoto N, Ugai T, Zhong R, et al. Rising incidence of early-onset colorectal cancer - a call to action. Nat Rev Clin Oncol. 2021;18(4):230–243. doi:10.1038/s41571-020-00445-1
   PubMed Web of Science ®Google Scholar
• Miles A, Van Duijnhoven F, McQueen A, Oliphant R. Colorectal cancer: advances in prevention and early detection. Biomed Res Int. 2015;2015:2. doi:10.1155/2015/518068
   Web of Science ®Google Scholar
• Castells A. Hereditary forms of colorectal cancer. Gastroenterol Hepatol. 2016;39(Suppl 1):62–67. doi:10.1016/S0210-5705(16)30176-5
   PubMedGoogle Scholar
• Song M, Garrett WS, Chan AT. Nutrients, foods, and colorectal cancer prevention. Gastroenterology. 2015;148(6):1244–1260 e1216. doi:10.1053/j.gastro.2014.12.035
   PubMed Web of Science ®Google Scholar
• Choi J, Jia G, Wen W, Shu XO, Zheng W. Healthy lifestyles, genetic modifiers, and colorectal cancer risk: a prospective cohort study in the UK biobank. Am J Clin Nutr. 2021;113(4):810–820. doi:10.1093/ajcn/nqaa404
   PubMed Web of Science ®Google Scholar
• Kuipers EJ, Grady WM, Lieberman D, et al. Colorectal cancer. Nat Rev Dis Primers. 2015;1:25. doi:10.1038/nrdp.2015.65
   Web of Science ®Google Scholar
• Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging. 2016;11:10 doi:10.2147/CIA.S109285.
   Web of Science ®Google Scholar
• Shao B, Yang W, Cao Q. Landscape and predictions of inflammatory bowel disease in China: china will enter the compounding prevalence stage around 2030. Front Public Health. 2022;10:1032679. doi:10.3389/fpubh.2022.1032679
   PubMed Web of Science ®Google Scholar
• Shaukat A, Theodore L . Current and future colorectal cancer screening strategies. Nature Reviews Gastroenterology & Hepatology. 2022;19():521–531 doi:10.1038/s41575-022-00612-y
   PubMed Web of Science ®Google Scholar
• Zygulska AL, Pierzchalski P. Novel Diagnostic Biomarkers in Colorectal Cancer. Int J Mol Sci. 2022,Jan 13;23(2):852. doi:10.3390/ijms23020852
   PubMed Web of Science ®Google Scholar
• Lu PX, Zhu XJ, Song YF, et al. Methylated septin 9 as a promising biomarker in the diagnosis and recurrence monitoring of colorectal cancer. Dis Markers. 2022;2022:8. doi:10.1155/2022/7087885
   Web of Science ®Google Scholar
• Burnett-Hartman AN, Lee JK, Demb J, Gupta S. An update on the epidemiology, molecular characterization, diagnosis, and screening strategies for early-onset colorectal cancer. Gastroenterology. 2021;160(4):1041–1049. doi:10.1053/j.gastro.2020.12.068
   PubMed Web of Science ®Google Scholar
• Ladabaum U, Dominitz JA, Kahi C, Schoen RE. Strategies for colorectal cancer screening. Gastroenterology. 2020;158(2):418–432. doi:10.1053/j.gastro.2019.06.043
   PubMed Web of Science ®Google Scholar
• Lansdorp-Vogelaar I, Knudsen AB, Brenner H. Cost-effectiveness of colorectal cancer screening. Epidemiol Rev. 2011;33(1):88–100. doi:10.1093/epirev/mxr004
   PubMed Web of Science ®Google Scholar
• Stevens GA, Alkema L, Black RE, et al. Guidelines for accurate and transparent health estimates reporting: the GATHER statement. Lancet. 2016;388(10062):e19–e23. doi:10.1016/S0140-6736(16)30388-9
   PubMed Web of Science ®Google Scholar